Scarica l'app Stockscreener
0.3669
11.64%
-0.0609
Precedente Chiudi:
$0.4278
Aprire:
$0.42
Volume 24 ore:
86,719
Relative Volume:
0.92
Capitalizzazione di mercato:
$5.29M
Reddito:
$389.00K
Utile/perdita netta:
$-13.13M
Rapporto P/E:
-0.3554
EPS:
-1.0323
Flusso di cassa netto:
$-11.90M
1 W Prestazione:
+8.34%
1M Prestazione:
+1.89%
6M Prestazione:
-74.11%
1 anno Prestazione:
-72.00%
Intervallo 1D:
$0.3479
$0.42
Intervallo di 1 settimana:
$0.3301
$0.43
Portata 52W:
$0.2711
$3.2324
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Nome
Collplant Biotechnologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare CLGN vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
0.3669 | 4.91M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
524.65 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.72 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.14 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.74 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.41 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-02-17 | Iniziato | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
CollPlant (Nasdaq: CLGN) raises $2.6M in share and warrant private deal - Stock Titan
CollPlant (CLGN) Secures $2.6 Million in Private Placement Offer - GuruFocus
CollPlant announces $2.6 million private placement By Investing.com - Investing.com Australia
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT - PR Newswire
CollPlant Biotechnologies Ltd. announced that it expects to receive $2.600001 million in funding - marketscreener.com
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBIT forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBITDA forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CollPlant Biotechnologies Ltd Actuals & Estimates (NASDAQ:CLGN) - TradingView
Collplant Biotechnologies Ltd (CLGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CLGN Technical Analysis & Stock Price Forecast - Intellectia AI
Collplant Biotechnologies Ltd (CLGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Collplant Biotechnologies Ltd (CLGN) Institutional Confidence - TradingKey
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Collplant Biotechnologies Ltd - TradingKey
CollPlant Heads Toward Nasdaq Deadline With Stock at 40 Cents - Bez Kabli
CollPlant Biotechnologies (CLGN) Holds Near Support Amidst Modest Downside PressureBear Flag - newsline.com
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy - Sahm
CollPlant Biotechnologies Posts Wider Q1 Loss as It Explores Strategic Alternatives and Advances Regenerative Aesthetics Pipeline - The Globe and Mail
CollPlant Biotechnologies (CLGN) Hovers Near Support at $0.38 After Marginal DeclineTrend Continuation Trade - The Legal Advocate
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy - Benzinga
CollPlant (CLGN) Reports Q1 2026 Financials and Strategic Updates - GuruFocus
CollPlant Q1 revenue falls to $73K, initiates strategic review - grafa.com
Collplant Biotechnologies: No Definitive Timetable for Process >CLGN - Moomoo
Collplant Biotechnologies: Initiates Process to Evaluate Strategic Alternatives Aimed at Maximizing Shareholder Value >CLGN - Moomoo
Collplant Biotechnologies 1Q Loss $3.1M >CLGN - Moomoo
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
Collplant ADR earnings beat by $0.03, revenue fell short of estimates - Investing.com
CLGNCollPlant Biotechnologies Ltd Stock Price and Quote - Finviz
CollPlant Biotechnologies (CLGN) Slips Slightly as Stock Tests Key Support near $0.40Market Leader Picks - newsline.com
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Quantisnow
CLGN Q4 2025 Earnings: Miss on EPS as Pre-Revenue Biotech Advances PipelineViral Trade Signals - Newser
CLGN Q1'26 Earnings: revenue estimate is 460.00K USD - TradingView
TradingKey - TradingKey
D. Boral Capital Maintains CollPlant Biotechnologies (CLGN) Buy Recommendation - MSN
CLGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Hugh M. Evans (CLGN) details CollPlant share, RSU and option holdings - Stock Titan
[EFFECT] CollPlant Biotechnologies Ltd SEC Filing - Stock Titan
CollPlant (CLGN) registers 3.296M shares for resale; warrants convertible into shares - Stock Titan
CollPlant (CLGN) Stock: Investment Potential Insight (Climbs) 2026-04-20Social Buzz Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Jasmine Seror Net Worth (2026) - GuruFocus
Avraham Havron Net Worth (2026) - GuruFocus
Elan Penn Net Worth (2026) - GuruFocus
Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.47%
2.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):